SPRAGUE JOHN M (Chief Financial Officer) sold 27.0% of their position (2.69K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $1.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/9/2023ACC: 0000899243-23-007726
Officer· Chief Financial Officer
Since Jul 2018
-2.69K
Net shares
Net seller
$1.7K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
6.91K acquired · 9.61K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+4K
Price / share
—
Trade value
—
% of position
131.3%
2/20/2023
3.05K→7.05K
Common Stock
Direct
Shares
−1.54K
Price / share
$0.65
Trade value
$1K
% of position
21.9%
2/22/2023
7.05K→5.50K
Common Stock
Direct
Shares
+2.91K
Price / share
—
Trade value
—
% of position
53.0%
2/24/2023
5.50K→8.42K
Common Stock
Direct
Shares
−1.15K
Price / share
$0.59
Trade value
$677.32
% of position
13.6%
2/28/2023
8.42K→7.27K
Total
Net shares
+4.22K
Net value
-$1.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2023 | M · Option Exercise | +4K | — | — | 131.3% | 3.05K | 7.05K |
| Common Stock Direct | 2/22/2023 | S · Sale | −1.54K | $0.65 | $1K | 21.9% | 7.05K | 5.50K |
| Common Stock Direct | 2/24/2023 | M · Option Exercise | +2.91K | — | — | 53.0% | 5.50K | 8.42K |
| Common Stock Direct | 2/28/2023 | S · Sale | −1.15K | $0.59 | $677.32 | 13.6% | 8.42K | 7.27K |
| Total | +4.22K | -$1.68K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
4K shares
Shares
−4K
Strike price
Held after
8K
Exercisable
—
2/20/2023
Restricted Stock Units
Direct
Converts to
Common Stock
2.91K shares
Shares
−2.91K
Strike price
Held after
2.91K
Exercisable
—
2/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock4K shares | 2/20/2023 | M · Option Exercise | −4K | — | 8K | |
| Restricted Stock Units Direct | Common Stock2.91K shares | 2/24/2023 | M · Option Exercise | −2.91K | — | 2.91K |